Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial

By sjmartinez • November 14, 2024

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Harrington MA, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM. Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial. Clin Infect Dis. 2024 Nov 11:ciae551. doi: 10.1093/cid/ciae551. Epub ahead of print. PMID: 39523543.

Tags: COVID-19 drug therapy, EPIC-HR, Infectious Diseases, nirmatrelvir, Publications, ritonavir, Symptoms

Repercussions of the COVID- 19 pandemic on maternal and congenital syphilis in South Brazil: a time series analysis 2010-2022

Echegaray F, Hernandez CJ, Sundar KG, Yang LZ, Cambou MC, Segura ER, de Melo MG, Santos BR, Dos Santos Varella IR, Nielsen-Saines K. Repercussions of[...]

Disseminated coccidioidomycosis presenting as eosinophilic ascites

Fetters KB, Fernandez-Hazoury D, Grujic S, Lee P. Disseminated coccidioidomycosis presenting as eosinophilic ascites. BMJ Case Rep. 2025 Apr 15;18(4):e263734. doi: 10.1136/bcr-2024-263734. PMID: 40234081.

Executive Orders and Caring for Our Transgender Patients

Vijayan T. Executive Orders and Caring for Our Transgender Patients. Clin Infect Dis. 2025 Apr 15:ciaf128. doi: 10.1093/cid/ciaf128. Epub ahead of print. PMID: 40230088.